TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Seer Stock

Seer Stock

seer.bioHealthcareFounded: 2017Funding to Date: $108.5MM

Seer is a provider of innovative solutions that act as a gateway to the proteome.

Learn more about Seer IPO
Register for Details

For more details on financing and valuation for Seer, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Seer.

Register Today

Team

Management Team

Robert Langer Ph.D
Co-Founder, Board Member & Chairman of Scientific Advisory Board
Omid Farokhzad MD
Co-Founder, Chief Executive Officer & Board Member
Philip Ma Ph.D
Co-Founder, President & Chief Business Officer

Board Members

Mark McClellan Ph.D
Terrance McGuire
David Hallal
Omid Farokhzad MD
David Singer
Maverick Ventures
Robert Langer Ph.D

Other companies like Seer in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Genomeweb 02/28/2022
Seer Q4 Revenues Grow Nearly Tenfold
The company posted revenues of $3.1 million, up from $336,000 in the year-ago period and beating the consensus Wall Street estimate of $2.2 million.
Genomeweb 11/12/2021
Seer Collaborators Release Data Indicating Proteograph Platform's Utility for Proteomics Research
The company and its early-access users have recently published data from several studies indicating that its platform can boost plasma proteome coverage.
Genomeweb 08/12/2021
Seer Q2 Revenues Skyrocket; Firm Inks Chinese Distribution Deal
The company posted revenues of $1.3 million, up from $71,000 in the year-ago period and above the consensus Wall Street estimate of $790,000.

Trending Companies

Frequently Asked Questions